Planning for a paradigm shift in the delivery of PV services, AWINSA provides end-to-end services including in its ambit both clinical trial and post-marketing.
Princeton
Joined April 2018
- Tweets688
- Following12
- Followers29
- Likes32
As we celebrate the Festival of Lights, may every diya bring positivity, prosperity, and joy to you and your loved ones.
At AWINSA, we wish our colleagues, clients, partners, and their families a joyful and prosperous Diwali filled with peace, good health, and success.
#AWINSA
EudraVigilance compliance requires ongoing maintenance, not just initial registration. Updates to RP/QPPV, access controls, and XEVMPD data can affect regulatory readiness.
AWINSA helps sponsors stay audit-ready with EU PV compliance support.
Early changes in ALT, AST, ALP, bilirubin, or PT (INR) may signal DILI. Recognizing these patterns early is critical to patient safety.
At AWINSA, we supports pharma and biotech sponsors with clinical safety, signal management, and risk management.
#PV #AWINSA #DrugSafety
AWINSA is proud to be a Gold Sponsor of WHY Summit 2026, Dec 2–3 in San Diego, USA.
Do not miss Dr Sanjeev Miglani, MD’s session on “Artificial Intelligence in aggregate reporting in global clinical trials: driving efficiency and scientific insight.”
On World Stroke Day, we are reminded of the importance of recognizing the signs, understanding the risks, & acting early. At AWINSA, patient safety reinforces a simple principle: awareness, timely action, and a focus on safety can make a meaningful difference to patient outcomes.
Pediatric medicines demand unique safety oversight. Children’s evolving physiology can alter drug response, with risks surfacing months or years later. At AWINSA, we supports pharma & biotech with pediatric PV, signal detection, risk management, and end‑to‑end safety operations.
AWINSA is proud to be a Gold Sponsor of the WHY Summit 2026, Dec 2–3 in San Diego, USA.
Don’t miss Dr. Mugdha Chopra’s session on AI challenges in Aggregate Safety Reporting in Global Clinical Trials.
Day 1 at the World Patient Safety Congress Americas is underway! AWINSA team is excited to connect with sponsors, CROs, and industry innovators to discuss the future of pharmacovigilance, safety operations, aggregate reporting, and literature surveillance. Visit us at Booth 325.
Excited to be at the World Patient Safety Congress Americas 2026 in Boston! 😊 Visit us at Booth 325 to explore how AWINSA supports pharma and biotech organizations with PV, Clinical Safety, Medical Writing, Medical Information, and patient safety solutions. Let's connect!
Meet our Leadership Team at World Patient Safety Congress Americas 2026, October 13-15, 2026 at booth #325, M.Menino Convention and Exhibition Center, Boston, to learn more about our Pharmacovigilance, Clinical Safety, Medical Writing, and Medical Information services.
Meet our Leadership Team at World Patient Safety Congress Americas 2026, October 13-15, 2026 at booth #325, M.Menino Convention and Exhibition Center, Boston, to learn more about our Pharmacovigilance, Clinical Safety, Medical Writing, and Medical Information services.
#AWINSA
Navigating Drug-Induced Kidney Injury requires a lifecycle approach to safety. AWINSA supports organizations with pharmacovigilance, signal management, aggregate reporting, and risk management to strengthen patient safety and compliance. #DrugSafety #AWINSA
Global literature monitoring is more than compliance. It is a vital source of safety intelligence. At AWINSA, we help pharma and biotech turn published data into actionable insights with end to end pharmacovigilance, clinical safety, signal management and global surveillance.
Meet our Leadership Team at World Patient Safety Congress Americas 2026, October 13-15, 2026 at booth #325, M.Menino Convention and Exhibition Center, Boston, to learn more about our Pharmacovigilance, Clinical Safety, Medical Writing, and Medical Information services.
We are hiring! Join us.
We are actively seeking: Pharmacovigilance Physicians/Medical Monitors (MBBS/MD) with 2 to 3 years of experience. This is an office-based position.
Interested candidates, please forward your resume to hr@awinsals.com
And that’s a wrap from #WPSC2026 Europe in Amsterdam! 😊 Great conversations, valuable connections, and exciting opportunities. Thanks to everyone who visited the AWINSA Life Sciences booth. We look forward to continuing the discussions and collaborating ahead.
The first day of the World Patient Safety Congress Europe 2026 has been filled with great conversations, fresh perspectives, and a shared commitment to improving patient safety. AI in PV was a key topic, showing how innovation and expertise can strengthen patient safety.
Ready for #WPSC2026 Amsterdam! 😊 Visit AWINSA Life Sciences at Booth 510 to discover how we support Pharma & Biotech organizations with Pharmacovigilance, Clinical Safety, Medical Writing, Medical Information, and end to end Patient Safety solutions. Let's connect....
Kidney disease trials pose pharmacovigilance challenges due to renal variability, complications, and intensive lab monitoring. AWINSA delivered end to end safety support for a global Phase 3 PMN programme, ensuring safety, data integrity, and compliance. awinsals.com/case-details/pr…
Remembering with dignity, raising awareness, supporting caregivers, promoting early recognition, and strengthening safe, compassionate care for people living with Alzheimer's and dementia.
#WorldAlzheimersDay
#AWINSA #DrugSafety #Pharmacovigilance #PatientSafety #RiskManagement
